( October 28, 2026, 3:01 PM EDT) -- TRENTON, N.J. — A New Jersey federal judge declined to grant a preliminary injunction sought by Novo Nordisk Inc. to halt certain advertising by Eli Lilly and Co. that compares the effectiveness of competing glucagon-like peptide-1 (GLP-1) receptor agonist medications....